SLC began as an API company but has since become a vertically integrated supplier of finished dosage formulations.


Vertical Integration Stage

  • 2016 –   US ANDA Approval for Meropenem
  • 2014- Injection Plant(IP)in Tainan, Taiwan Passes US FDA cGMP Audit
  • 2013- Injectable facility passes Spain AEMPS inspection
  • 2013- Injectable facility passes Taiwan TFDA inspection
  • 2012- Savior Lifetec Corporation (4167.TWO) registered on the Emerging Board
  • 2011- Injectable plant at Tainan Science Park established

Founding Stage

  • 2011- API facility passes US FDA inspection
  • 2010- API facility passes UK MHRA inspection
  • 2009- API facility passes Japan PMDA inspection
  • 2007- First to register US DMF for Meropenem
  • 2006- Branch site at Tainan Science Park established
  • 2006- API facility passes Taiwan Ministry of Health inspection
  • 2006- First to register US DMF for Imipenem-Cilastatin
  • 2004- HQ site at Chunan Science Park established